Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Stopping Plasmodium Parasite Invasion by Boosting Humoral Immunity.

Vinchi F, Lobo CA.

Hemasphere. 2019 Jun 4;3(3):e206. doi: 10.1097/HS9.0000000000000206. eCollection 2019 Jun. Review. No abstract available.

PMID:
31723834
2.

Comparative and functional genomics of the protozoan parasite Babesia divergens highlighting the invasion and egress processes.

González LM, Estrada K, Grande R, Jiménez-Jacinto V, Vega-Alvarado L, Sevilla E, Barrera J, Cuesta I, Zaballos Á, Bautista JM, Lobo CA, Sánchez-Flores A, Montero E.

PLoS Negl Trop Dis. 2019 Aug 19;13(8):e0007680. doi: 10.1371/journal.pntd.0007680. eCollection 2019 Aug.

3.

Babesia divergens: A Drive to Survive.

Lobo CA, Cursino-Santos JR, Singh M, Rodriguez M.

Pathogens. 2019 Jul 2;8(3). pii: E95. doi: 10.3390/pathogens8030095. Review.

4.

Altered parasite life-cycle processes characterize Babesia divergens infection in human sickle cell anemia.

Cursino-Santos JR, Singh M, Senaldi E, Manwani D, Yazdanbakhsh K, Lobo CA.

Haematologica. 2019 Nov;104(11):2189-2199. doi: 10.3324/haematol.2018.214304. Epub 2019 Mar 28.

5.

Deletion of a flippase subunit Tmem30a in hematopoietic cells impairs mouse fetal liver erythropoiesis.

Yang F, Huang Y, Chen X, Liu L, Liao D, Zhang H, Huang G, Liu W, Zhu X, Wang W, Lobo CA, Yazdanbakhsh K, An X, Ju Z.

Haematologica. 2019 Oct;104(10):1984-1994. doi: 10.3324/haematol.2018.203992. Epub 2019 Feb 28.

6.

Robust adaptive immune response against Babesia microti infection marked by low parasitemia in a murine model of sickle cell disease.

Yi W, Bao W, Rodriguez M, Liu Y, Singh M, Ramlall V, Cursino-Santos JR, Zhong H, Elton CM, Wright GJ, Mendelson A, An X, Lobo CA, Yazdanbakhsh K.

Blood Adv. 2018 Dec 11;2(23):3462-3478. doi: 10.1182/bloodadvances.2018026468.

7.

A library of recombinant Babesia microti cell surface and secreted proteins for diagnostics discovery and reverse vaccinology.

Elton CM, Rodriguez M, Ben Mamoun C, Lobo CA, Wright GJ.

Int J Parasitol. 2019 Feb;49(2):115-125. doi: 10.1016/j.ijpara.2018.10.003. Epub 2018 Oct 24.

8.

A novel flow cytometric application discriminates among the effects of chemical inhibitors on various phases of Babesia divergens intraerythrocytic cycle.

Cursino-Santos JR, Singh M, Pham P, Lobo CA.

Cytometry A. 2017 Mar;91(3):216-231. doi: 10.1002/cyto.a.23062. Epub 2017 Feb 16.

9.

Ultrasound-guided approach to nerves (direct vs. tangential) and the incidence of intraneural injection: a cadaveric study.

Sermeus LA, Sala-Blanch X, McDonnell JG, Lobo CA, Nicholls BJ, van Geffen GJ, Choquet O, Iohom G, de Jose Maria Galve B, Hermans C, Lammens M.

Anaesthesia. 2017 Apr;72(4):461-469. doi: 10.1111/anae.13787. Epub 2017 Feb 10.

10.

First Report of Babesia microti-Caused Babesiosis in Spain.

Arsuaga M, Gonzalez LM, Lobo CA, de la Calle F, Bautista JM, Azcárate IG, Puente S, Montero E.

Vector Borne Zoonotic Dis. 2016 Oct;16(10):677-9. doi: 10.1089/vbz.2016.1946. Epub 2016 Aug 25.

11.

Identification and Characterization of the Rhoptry Neck Protein 2 in Babesia divergens and B. microti.

Ord RL, Rodriguez M, Cursino-Santos JR, Hong H, Singh M, Gray J, Lobo CA.

Infect Immun. 2016 Apr 22;84(5):1574-1584. doi: 10.1128/IAI.00107-16. Print 2016 May.

12.

Babesia divergens builds a complex population structure composed of specific ratios of infected cells to ensure a prompt response to changing environmental conditions.

Cursino-Santos JR, Singh M, Pham P, Rodriguez M, Lobo CA.

Cell Microbiol. 2016 Jun;18(6):859-74. doi: 10.1111/cmi.12555. Epub 2016 Jan 20.

PMID:
26663747
13.

Human Babesiosis: Pathogens, Prevalence, Diagnosis and Treatment.

Ord RL, Lobo CA.

Curr Clin Microbiol Rep. 2015 Dec;2(4):173-181. Epub 2015 Sep 28.

14.

Babesia divergens apical membrane antigen-1 (BdAMA-1): A poorly polymorphic protein that induces a weak and late immune response.

Moreau E, Bonsergent C, Al Dybiat I, Gonzalez LM, Lobo CA, Montero E, Malandrin L.

Exp Parasitol. 2015 Aug;155:40-5. doi: 10.1016/j.exppara.2015.04.024. Epub 2015 May 5.

PMID:
25956948
15.

Malaria invasion ligand RH5 and its prime candidacy in blood-stage malaria vaccine design.

Ord RL, Rodriguez M, Lobo CA.

Hum Vaccin Immunother. 2015;11(6):1465-73. doi: 10.1080/21645515.2015.1026496. Review.

16.

The safety of general anaesthesia in paediatric patients undergoing the application of Biobrane® for small scalds.

Warwicker SJ, Lobo CA, Dailami N, Young AE.

Burns. 2015 Sep;41(6):1221-6. doi: 10.1016/j.burns.2015.02.007. Epub 2015 Feb 25.

PMID:
25724104
17.

First report of Babesia divergens infection in an HIV patient.

González LM, Castro E, Lobo CA, Richart A, Ramiro R, González-Camacho F, Luque D, Velasco AC, Montero E.

Int J Infect Dis. 2015 Apr;33:202-4. doi: 10.1016/j.ijid.2015.02.005. Epub 2015 Feb 14.

18.

High-Quality Draft Genome Sequence of Babesia divergens, the Etiological Agent of Cattle and Human Babesiosis.

Cuesta I, González LM, Estrada K, Grande R, Zaballos A, Lobo CA, Barrera J, Sanchez-Flores A, Montero E.

Genome Announc. 2014 Nov 13;2(6). pii: e01194-14. doi: 10.1128/genomeA.01194-14.

19.

Rescuing the obese or burned airway: are conventional training manikins adequate? A simulation study.

Howes TE, Lobo CA, Kelly FE, Cook TM.

Br J Anaesth. 2015 Jan;114(1):136-42. doi: 10.1093/bja/aeu336. Epub 2014 Oct 8.

20.

Identification and characterization of the RouenBd1987 Babesia divergens Rhopty-Associated Protein 1.

Rodriguez M, Alhassan A, Ord RL, Cursino-Santos JR, Singh M, Gray J, Lobo CA.

PLoS One. 2014 Sep 16;9(9):e107727. doi: 10.1371/journal.pone.0107727. eCollection 2014.

21.

A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein.

Ord RL, Caldeira JC, Rodriguez M, Noe A, Chackerian B, Peabody DS, Gutierrez G, Lobo CA.

Malar J. 2014 Aug 18;13:326. doi: 10.1186/1475-2875-13-326.

22.

Severe babesiosis in immunocompetent man, Spain, 2011.

Gonzalez LM, Rojo S, Gonzalez-Camacho F, Luque D, Lobo CA, Montero E.

Emerg Infect Dis. 2014 Apr;20(4):724-6. doi: 10.3201/eid2004.131409. No abstract available.

23.

Femoral nerve-artery relation in patients with proximal femur fractures.

Lobo CA, Pinheiro CM, Rodrigues MG, Fondi MA.

J Clin Anesth. 2013 Nov;25(7):600-2. doi: 10.1016/j.jclinane.2012.12.008. Epub 2013 Aug 30. No abstract available.

PMID:
23999239
24.

Identification of binding domains on red blood cell glycophorins for Babesia divergens.

Cursino-Santos JR, Halverson G, Rodriguez M, Narla M, Lobo CA.

Transfusion. 2014 Apr;54(4):982-9. doi: 10.1111/trf.12388. Epub 2013 Aug 14.

25.

Babesia: impact of cold storage on the survival and the viability of parasites in blood bags.

Cursino-Santos JR, Alhassan A, Singh M, Lobo CA.

Transfusion. 2014 Mar;54(3):585-91. doi: 10.1111/trf.12357. Epub 2013 Jul 28.

26.

Babesia: an emerging infectious threat in transfusion medicine.

Lobo CA, Cursino-Santos JR, Alhassan A, Rodrigues M.

PLoS Pathog. 2013;9(7):e1003387. doi: 10.1371/journal.ppat.1003387. Epub 2013 Jul 11. No abstract available.

27.

Babesia and red cell invasion.

Lobo CA, Rodriguez M, Cursino-Santos JR.

Curr Opin Hematol. 2012 May;19(3):170-5. doi: 10.1097/MOH.0b013e328352245a. Review.

PMID:
22488304
28.

Targeting sialic acid dependent and independent pathways of invasion in Plasmodium falciparum.

Ord RL, Rodriguez M, Yamasaki T, Takeo S, Tsuboi T, Lobo CA.

PLoS One. 2012;7(1):e30251. doi: 10.1371/journal.pone.0030251. Epub 2012 Jan 12.

29.

Review of studies and guidelines on fasting and procedural sedation at the emergency department.

Molina JA, Lobo CA, Goh HK, Seow E, Heng BH.

Int J Evid Based Healthc. 2010 Jun;8(2):75-8. doi: 10.1111/j.1744-1609.2010.00163.x. Review.

PMID:
20923510
30.

Babesia divergens apical membrane antigen 1 and its interaction with the human red blood cell.

Montero E, Rodriguez M, Oksov Y, Lobo CA.

Infect Immun. 2009 Nov;77(11):4783-93. doi: 10.1128/IAI.00969-08. Epub 2009 Aug 31.

31.

PfRH5: a novel reticulocyte-binding family homolog of plasmodium falciparum that binds to the erythrocyte, and an investigation of its receptor.

Rodriguez M, Lustigman S, Montero E, Oksov Y, Lobo CA.

PLoS One. 2008 Oct 1;3(10):e3300. doi: 10.1371/journal.pone.0003300. Erratum in: PLoS One. 2008;3(11). doi: 10.1371/annotation/dde6c172-c9c3-43bb-8fc3-db54613d4424.

32.

Babesia divergens: identification and characterization of BdHSP-20, a small heat shock protein.

Montero E, Rodriguez M, Gonzalez LM, Lobo CA.

Exp Parasitol. 2008 Jun;119(2):238-45. doi: 10.1016/j.exppara.2008.01.020. Epub 2008 Feb 13.

PMID:
18346739
33.

Differential antibody responses to Plasmodium falciparum invasion ligand proteins in individuals living in malaria-endemic areas in Brazil and Cameroon.

Ford L, Lobo CA, Rodriguez M, Zalis MG, Machado RL, Rossit AR, Cavasini CE, Couto AA, Enyong PA, Lustigman S.

Am J Trop Med Hyg. 2007 Nov;77(5):977-83.

PMID:
17984363
34.

Inhibition of human erythrocyte invasion by Babesia divergens using serine protease inhibitors.

Montero E, Rafiq S, Heck S, Lobo CA.

Mol Biochem Parasitol. 2007 May;153(1):80-4. Epub 2007 Jan 26. No abstract available.

PMID:
17320984
35.

Sexual differentiation and development in the malaria parasite.

Lobo CA, Kumar N.

Parasitol Today. 1998 Apr;14(4):146-50.

PMID:
17040732
36.

A conserved subtilisin protease identified in Babesia divergens merozoites.

Montero E, Gonzalez LM, Rodriguez M, Oksov Y, Blackman MJ, Lobo CA.

J Biol Chem. 2006 Nov 24;281(47):35717-26. Epub 2006 Sep 18.

37.

Associations between defined polymorphic variants in the PfRH ligand family and the invasion pathways used by P. falciparum field isolates from Brazil.

Lobo CA, Rodriguez M, Struchiner CJ, Zalis MG, Lustigman S.

Mol Biochem Parasitol. 2006 Oct;149(2):246-51. Epub 2006 Jun 23. No abstract available.

PMID:
16857278
39.

Invasion profiles of Brazilian field isolates of Plasmodium falciparum: phenotypic and genotypic analyses.

Lobo CA, de Frazao K, Rodriguez M, Reid M, Zalis M, Lustigman S.

Infect Immun. 2004 Oct;72(10):5886-91.

40.

Characterization of PfRhop148, a novel rhoptry protein of Plasmodium falciparum.

Lobo CA, Rodriguez M, Hou G, Perkins M, Oskov Y, Lustigman S.

Mol Biochem Parasitol. 2003 Apr 25;128(1):59-65.

PMID:
12706797
41.

Glycophorin C is the receptor for the Plasmodium falciparum erythrocyte binding ligand PfEBP-2 (baebl).

Lobo CA, Rodriguez M, Reid M, Lustigman S.

Blood. 2003 Jun 1;101(11):4628-31. Epub 2003 Feb 6.

PMID:
12576308
42.

Cloning and characterization of a new asparagine-rich protein in Plasmodium falciparum.

Zhang K, Fujioka H, Lobo CA, Kitayaporn D, Aikawa M, Kumar N.

Parasitol Res. 1999 Dec;85(12):956-63.

PMID:
10599917
43.
44.
45.
46.

Homocystinuria: a cause of hypercoagulability that may be unrecognized.

Lobo CA, Millward SF.

J Vasc Interv Radiol. 1998 Nov-Dec;9(6):971-5. No abstract available.

PMID:
9840044
47.

Expression of early gametocyte-stage antigens Pfg27 and Pfs16 in synchronized gametocytes and non-gametocyte producing clones of Plasmodium falciparum.

Lobo CA, Konings RN, Kumar N.

Mol Biochem Parasitol. 1994 Nov;68(1):151-4. No abstract available.

PMID:
7891740
48.

Novel proteins of Plasmodium falciparum identified by differential immunoscreening using immune and patient sera.

Lobo CA, Kar SK, Ravindran B, Kabilan L, Sharma S.

Infect Immun. 1994 Feb;62(2):651-6.

49.

Differentiation of type A foot-and-mouth disease virus subtypes by double- and radial-immunodiffusion analysis.

Lobo CA, Cowan KM, Trautman R, Hanson RP.

Am J Vet Res. 1974 Aug;35(8):1121-6. No abstract available.

PMID:
4368590
50.

Complement-fixation analysis of four subtypes of foot-and-mouth disease virus type A.

Lobo CA, Cowan KM, Hanson RP.

Appl Microbiol. 1973 Oct;26(4):570-3.

Supplemental Content

Support Center